Polydioxanone Sutures | Duracryl

DURACRYL - PDS SUTURE

• Features

  • Polydioxanone suture is a synthetic, monofilament absorbable suture.
  • Polydioxanone sutures are available from U.S.P. size 2 to size 6-0. Sutures are available in violet colour.
  • Polydioxanone sutures are composed of polymers made from 100% homopolymer of polydioxanone.
  • Polydioxanone sutures absorb by simple hydrolytic mechanism and absorption is predictable.
  • Polydioxanone sutures retain about 70% of the initial tensile strength after 2 weeks, 50% of the initial tensile strength after 4 weeks and 25% after 6 weeks of implantation and the suture is essentially absorbed within 180 days.

• Advantages

  • Duracryl sutures pass through tissue easily causing very little trauma.
  • Duracryl sutures have good knot security and it has easy knot placement.
  • Duracryl sutures have the highest tensile strength compared to any other synthetic absorbable sutures and it is absorbed over a longer period of time hence can be used where long term tissue approximation is required.
  • Duracryl sutures are available with needles made from 300 series alloy steel for superior strength, sharpness and performance.

• Models

  CODE NO.	NEEDLE PROFILE	NEEDLE LENGTH	SUTURE LENGTH	SUTURE SIZE
  FS 9237	1/2 circle round body	20mm	70cm	3-0
  FS 9018	3/8 circle cutting	22mm	90cm	3-0
  FS 9133	1/2 circle round body	30mm	70 cms	2-0
  FS 9133S	1/2 circle round body	30mm	45cm	2-0
  FS 9254	1/2 circle round body (heavy)	30mm	70cm	0
  FS 9371	1/2 circle round body (heavy)	40mm	90cm	0
  FS 9260	1/2 circle round body (heavy)	40mm	150cm LOOP	0
  FS 9248	1/2 circle round body (heavy)	40mm	90cm	1
  PDS 2160	1/2 circle round body D.N	40mm	160cm	1
  FS 9262	1/2 circle round body (heavy)LOOP	50mm	150cm	1
  FS 9374	1/2 circle reverse cutting (heavy)	50mm	90cm	1
  TS 9237	1/2 circle round body	20mm	70cm	3-0
  TS 9018	3/8 circle cutting	22mm	90cm	3-0
  TS 9133	1/2 circle round body	30mm	70 cms	2-0
  TS 9133S	1/2 circle round body	30mm	45cm	2-0
  TS 9254	1/2 circle round body (heavy)	30mm	70cm	0
  TS 9371	1/2 circle round body (heavy)	40mm	90cm	0
  TS 9260	1/2 circle round body (heavy)	40mm	150cm LOOP	0
  TS 9248	1/2 circle round body (heavy)	40mm	90cm	1
  PDS 2160	1/2 circle round body D.N	40mm	160cm	1
  TS 9262	1/2 circle round body (heavy)LOOP	50mm	150cm	1
  TS 9374	1/2 circle reverse cutting (heavy)	50mm	90cm	1

• Packing

  • Polydioxanone sutures are individually packed in a primary medical grade paper folder
  • Individually packed sutures are then packed in a tear-open or peel-open aluminum foil, with less than 300ppm moisture
  • Aluminum foils are further packed in a secondary medical grade paper pouch laminated with polyester laminated poly film
  • Sutures are further packed in small cartons made from premium 320 GSM Cyber XLPac in 12 suture pack
  • Boxes are further laminated in tamper proof film to protect it from dirt/dust
  • Further, the sutures are packed in an export worthy 7 ply master carton which can accommodate 100 boxes ( 70 x 30 x 30 cms) – weighing up to 9 to 10kg and 200 boxes ( 70 x 29 x 59 cms) – weighing up to 18kg

• Usage

  DURACRYL®

  STERLE ABSORBABLE SURGICAL SUTURE

  DESCRIPTION

  DURACRYL® is a sterile synthetic absorbable monofilament suture composed of Poly (p-dioxanone). The empirical formula of the polymer is (C₄H₆O₃)_n Polydioxanone polymer has been found to be non-antigenic, non-pyrogenic and elicits only a slight tissue reaction during absorption. Polydioxanone sutures are dyed by adding D & C violet No 2. (Colour Index No. 60725) during polymerization. Duracryl sutures are available in range of gauge sizes and lengths, non needled or attached to stainless steel needles of varying types, sizes and shapes. The needles are attached permanently to the suture. Entire details of the product range are available in the catalogue.

  INDICATIONS
  Polydioxanone monofilament synthetic absorbable sutures are indicated for use in all types of soft tissue approximation, including use in pediatric cardiovascular tissue where growth is expected to occur, and ophthalmic surgery. Polydioxanone suture is not indicated in adult cardiovascular tissue, microsurgery and neural tissue. These sutures are particularly useful where the combination of an absorbable suture and extended wound support (up to six weeks) is desirable.

  SELECTION CRITERIA

  DURACRYL® sutures should be selected and implanted depending on the patient’s condition, surgical experience, surgical technique and wound size.

  PERFORMANCE

  DURACRYL® suture leads to ingrowth of fibrous connective tissue due to minimal initial inflammatory tissue reaction. DURACRYL® gradually loses tensile strength and is finally absorbed by hydrolytic process. During hydrolysis, the co-polymer degrades monomeric acid to 2 hydroxyethoxyacetic acid which subsequently absorbed and eliminated by the body. Absorption begins as a loss of tensile strength followed by a loss of mass. Absorption pattern for suture when tested on rats:-

  Approx 78.45 % of tensile strength at 14 days,

  Approx 69.7 % tensile strength after 28 days and

  Approx 57.95 % tensile strength after 43 days.

  Approx 40.55 % tensile strength after 57 days.

  ADVERSE REACTIONS

  Adverse reaction, associated with the use of the device include transitory local irritation at the wound site, transitory inflammatory foreign body response, erythema and induration during the absorption process of subcuticular sutures. Like all foreign bodies, DURACRYL® suture may enhance an existing infection.

  CONTRAINDICATIONS
  DURACRYL® sutures, being absorbable, are not to be used where prolonged (beyond six weeks) approximation of tissues under stress is required and are not to be used in conjunction with prosthetic devices, i.e., heart valves or synthetic grafts. The use of this suture is contraindicated in patients with known sensitivities or allergies to polydioxanone.

  WARNINGS

  1. Surgeons should be familiar with surgical procedures and techniques involving absorbable sutures before employing DURACRYL® suture for wound closure, as the risk of wound dehiscence may vary with the site of application and the suture material used.
  2. In surgery of the urinary or biliary tract, care should be taken to avoid prolonged contact of this or any other suture with salt solution, to prevent calculus formation.
  3. This suture many be inappropriate in patients suffering from conditions which may delay wound healing e.g., patient that are elder, malnourished or depilated. As this is an absorbable suture, the use of supplemental non-absorbable suture should be considered by the surgeon in the close of the abdomen, chest, joints or other sites subjects to expansion or requiring additional support.
  4. For single use only. Do not reuse, reprocess or re-sterilize. Reuse, reprocessing or re‐sterilization may compromise the structural integrity of the device and/ or lead to device failure which, in turn, may result in patient injury and illness.
  5. Reuse, reprocessing or re‐sterilization may also create a risk of contamination of the device and/or cause patient infection or cross‐infection, including, but not limited to, the transmission of infectious disease(s) from one patient to another.
  6. Contamination of the device may lead to injury, illness of the patient.

  PRECAUTIONS

  1. Acceptable surgical practice should be followed for the management of contaminated or infected wounds.
  2. Conjunctival and vaginal mucosal sutures remaining in place for extended periods may be associated with localized irritation and should be removed as indicated.
  3. Subcuticular sutures should be placed as deeply as possible in order to minimize the erythema and induration normally associated with absorption. Acceptable surgical practice should be followed with respect to drainage and closure of infected wounds.
  4. Consideration should be taken in the use of absorbable sutures in tissues with poor blood supply as suture extrusion and delayed absorption may occur.
  5. When handling this or any other suture, care should be taken to avoid damage from handling. Avoid crushing or crimping damage due to application of surgical instruments such as forceps or needle holders.
  6. Care should be taken to avoid damage while handling surgical needles. Grasp the needle in an area, one third (1/3) to one half (1/2) of the distance from the attachment end to the point.
  7. Grasping in the point area could impair the penetration performance and cause fracture of the needle.
  8. Grasping at the butt or attachment end could cause bending or breakage.
  9. Reshaping the needles may cause them to loose strength and make less resistant to bending and breaking.
  10. Users should exercise caution when handling surgical needles to avoid inadvertent needle stick injury. Discard the needles after use.

  STERILITY

  DURACRYL® sutures are sterilized by ethylene oxide. Do not re – sterilize! Do not use if package is opened or damaged! Discard opened unused sutures.

  STORAGE

  Recommended storage condition 10^oC-35°C, away from moisture and direct heat. Do not use after expiry date.

  DISPOSAL

  Discard used sutures and needles contaminated with blood in the container meant infectious waste. Unused expired pouches should be incinerated.